Day: September 14, 2023

On 14 September 2023, Enefit Green signed a €180 million loan agreement with European Investment Bank (EIB) to finance its ongoing investment programme. The term of the concluded contract is 12 years. Enefit Green will use the loan capital for the construction of the Sopi-Tootsi wind farm in Estonia. Sopi-Tootsi wind farm is the largest wind farm under construction in Estonia with a capacity of 255 MW. After its completion in 2025, this wind farm will cover approximately 40% of annual electricity consumption of Estonian households. Enefit Green is currently constructing five wind and three solar farms in Estonia, Lithuania, Poland and Finland with a total capacity of 608 MW. In 2023, Purtse hybrid wind and solar farm in Estonia and the Zambrow solar farm in Poland with a total capacity of 62MW have been completed and put into operation....

Press Release Report on the Extraordinary General Meeting held on September 12, 2023 andAnnouncement of an upward threshold crossing Bollène, September 13, 2023 – 06 :00pm (CET). Egide Group (Euronext Growth Paris™- ISIN: FR0000072373 – Mnemo: ALGID), the global specialist in hermetic packages and heat dissipation solutions for sensitive electronic components, informs its shareholders that the Extraordinary General Meeting met as scheduled on third call on Tuesday, September 12, 2023, at 10:30 am. Shareholders present or represented held 3,194,818 shares (i.e., 24.02% out of a total of 13,303,116 shares with voting rights at the date of the Meeting) and 3,203,743 votes (i.e., 23.98% out of a total of 13,359,172 voting rights). The Extraordinary General Meeting was therefore able to proceed, the 20% quorum required on third...

Paris, September 14, 2023 – Ipsos experiences continued growth but at slower pace than forecasted for 2023. The Group now expects organic growth between 3% to 4%, compared to “around 5%” at the start of the year. This revision is mainly due to the persistence of headwinds already mentioned in previous financial releases:In particular, the activity of major Tech customers did not improve during the summer. After an exceptional growth during the pandemic, these clients have been experiencing a period of uncertainty since autumn 2022. Despite a return to pre pandemic growth path, they remain major clients for Ipsos. In addition, new opportunities related to generative artificial intelligence arise.While our activity in North America will be impacted by the Tech sector and below our expectations, we anticipate a positive revenue growth...

Press Contact:Fahd PashaTel.: +1 647 860 3777E-mail: Fahd.Pasha@capgemini.com Global non-cash transaction volumes set to reach 1.3 trillion in 2023 By 2027, new digital payment methods will make up approximately 30% of total volume, with traditional payments dropping to around 70% of overall non-cash transaction volumes Paris, September 14, 2023 – The Capgemini Research Institute’s 2023 World Payments Report, published today, reveals non-cash transaction volumes will reach 1.3 trillion by 2023 globally. As consumers and businesses adopt new digital payment schemes, the report suggests this growth will accelerate to 2.3 trillion by 2027 growing at a rate of 15% annually. At a regional level, digital payments will grow by 19.8% across the Asia Pacific, 10.7% in Europe, and 6.5% in North America by 2027. The expanding digital payment infrastructure,...

Image 1Archer’s advanced gFET chip for advanced biosensing diced from the whole four-inch wafer fabricated in a commercial foundry.HighlightsArcher Materials’ commercial foundry partner in the Netherlands has validated its advanced biochip gFET design by manufacturing the chips using whole four-inch wafer semiconductor fabrication processes. The new gFET design for multiplexing was fabricated at a commercial scale foundry. The validation of the new advanced gFET device design and whole wafer run in a commercial foundry represents a critical milestone in the commercialisation pathway for Archer’s biochip. Archer now intends to integrate more functionality on the biochip, and optimise the device size and geometry to build advanced sensing regions. The biochip designs and devices form the basis of intellectual property that is...